(Q34194073)

31 July 2017

1 reference

title

Photodynamic therapy for cancer. (English)

1 reference

31 July 2017

3

Rakesh K Jain

1 reference

31 July 2017

2

Dai Fukumura

1 reference

31 July 2017

Dennis E J G J Dolmans

series ordinal

1

object named as

Dennis E J G J Dolmans

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

31 July 2017

published in

Nature Reviews Cancer

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

380-387

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1071

31 July 2017

exact match

0 references

cites work

The history of photodetection and photodynamic therapy.

1 reference

Phototoxicity and photoallergy

31 March 2020

1 reference

Phototherapy and photochemotherapy

31 March 2020

1 reference

The photodynamic properties of a particular hematoporphyrin derivative

31 March 2020

1 reference

Photodynamic therapy of malignant tumours.

31 March 2020

1 reference

Photoradiation Therapy. II. Cure of Animal Tumors With Hematoporphyrin and Light23

31 March 2020

1 reference

Photodynamic destruction of human bladder carcinoma

31 March 2020

1 reference

Hematoporphyrin Derivative: A Possible Aid in the Diagnosis and Therapy of Carcinoma of the Bladder

31 March 2020

1 reference

Hematoporphyrin Derivative and Laser Photoradiation in the Treatment of Lung Cancer

31 March 2020

1 reference

Palliation of esophageal malignancy with photoradiation therapy

31 March 2020

1 reference

Photoradiation therapy of endobronchial lung cancers employing the photodynamic action of hematoporphvrin derivative

31 March 2020

1 reference

Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastrointestinal tract

31 March 2020

1 reference

In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer

31 March 2020

1 reference

The treatment of vaginal recurrences of gynecologic malignancy with phototherapy following hematoporphyrin derivative pretreatment

31 March 2020

1 reference

Photomedical approaches for the diagnosis and treatment of gynecologic cancers

31 March 2020

1 reference

Sister chromatid exchange rate and alkaline comet assay scores in patients with ovarian cancer

31 March 2020

1 reference

Photodynamic therapy for circumscribed choroidal haemangioma

31 March 2020

1 reference

Photodynamic therapy of brain tumors

31 March 2020

1 reference

Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin

31 March 2020

1 reference

Photodynamic therapy for treatment of head and neck cancer

31 March 2020

1 reference

Photodynamic therapy and the treatment of head and neck neoplasia.

31 March 2020

1 reference

Photodynamic therapy for colorectal cancer: a quantitative pilot study

31 March 2020

1 reference

Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies

31 March 2020

1 reference

Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors.

31 March 2020

1 reference

Intrapleural photodynamic therapy: results of a phase I trial

31 March 2020

1 reference

Photodynamic therapy of nonresectable cholangiocarcinoma.

31 March 2020

1 reference

Photodynamic therapy for cancer of the pancreas.

31 March 2020

1 reference

How does photodynamic therapy work?

31 March 2020

1 reference

Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions

31 March 2020

1 reference

The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen

31 March 2020

1 reference

Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply

31 March 2020

1 reference

In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy

31 March 2020

1 reference

Analysis of the heterogeneity of pO2 dynamics during photodynamic therapy with verteporfin

31 March 2020

1 reference

Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies

31 March 2020

1 reference

A theoretical study of light fractionation and dose-rate effects in photodynamic therapy.

31 March 2020

1 reference

Angiogenesis in cancer and other diseases

31 March 2020

1 reference

Vessels of death or life.

31 March 2020

1 reference

The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using photofrin

31 March 2020

1 reference

Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).

31 March 2020

1 reference

Tumor oxygenation changes post-photodynamic therapy

31 March 2020

1 reference

Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model

31 March 2020

1 reference

Clinical laser photodynamic therapy in the treatment of bladder carcinoma.

31 March 2020

1 reference

Delivery of molecular and cellular medicine to solid tumors

31 March 2020

1 reference

The next frontier of molecular medicine: delivery of therapeutics.

31 March 2020

1 reference

An update on photodynamic therapy applications

31 March 2020

1 reference

Foscan uptake and tissue distribution in relation to photodynamic efficacy

31 March 2020

1 reference

Specialization of tumour vasculature

31 March 2020

1 reference

Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy

31 March 2020

1 reference

Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres

31 March 2020

1 reference

Hematoporphyrin as a photosensitizer of tumors

31 March 2020

1 reference

A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model

31 March 2020

1 reference

Photodynamic therapy in oncology

31 March 2020

1 reference

Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results

31 March 2020

1 reference

Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin

31 March 2020

1 reference

Clinical pharmacokinetic studies of photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi.

31 March 2020

1 reference

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

31 March 2020

1 reference

Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results

31 March 2020

1 reference

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

31 March 2020

1 reference

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration

31 March 2020

1 reference

Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation

31 March 2020

1 reference

Recent advances in the management of age-related macular degeneration

31 March 2020

1 reference

Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia

31 March 2020

1 reference

Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium.

31 March 2020

1 reference

Non-oncologic indications for ALA-PDT.

31 March 2020

1 reference

Photodynamic therapy: applications in dermatology

31 March 2020

1 reference

Optical monitoring and treatment of potentially lethal wound infections in vivo

31 March 2020

1 reference

Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment

31 March 2020

1 reference

Antibody-directed effector cell therapy of tumors: analysis and optimization using a physiologically based pharmacokinetic model

31 March 2020

1 reference

Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative

31 March 2020

1 reference

State of the art in the delivery of photosensitizers for photodynamic therapy

31 March 2020

1 reference

Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts

31 March 2020

1 reference

The role of the peripheral benzodiazepine receptor in photodynamic activity of certain pyropheophorbide ether photosensitizers: albumin site II as a surrogate marker for activity

31 March 2020

1 reference

An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells

31 March 2020

1 reference

An ultrastructural comparative evaluation of tumors photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins

31 March 2020

1 reference

Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model

31 March 2020

1 reference

A history of photodynamic therapy

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Photodynamic therapy: a 5-year study of its effectiveness in the treatment of posterior uveal melanoma, and evaluation of haematoporphyrin uptake and photocytotoxicity of melanoma cells in tissue culture.

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC1071

1 reference

Dimensions Publication ID

31 July 2017

1039940247

0 references

1 reference